Background: This study was aimed to evaluate the influence of oral N-acetylcysteine (NAC) application as an adjuvant to letrozole on induced ovulation outcomes in patients with polycystic ovary syndrome (PCOS).
Materials and methods: This was a placebo-controlled double-blind randomized clinical trial with 130 PCOS patients who were infertile. First, patients were randomly divided into two groups. Patients in Group 1 were administered letrozole 5 mg/d plus NAC 1.2 g/d and patients in Group 2 were administered letrozole plus placebo for 5 days starting at the 3rd day of the menstruation period. On the 12th day of the cycle, ultrasound evaluation was performed, and in whom at least one follicle with an 18-20 mm diameter was found, 10,000 unit human chorionic gonadotropin (hCG) was prescribed, and 36 h after hCG injection, timed intercourse was advised. On the 16th day, after hCG injection, serum β-hCG level was evaluated.
Results: The number of follicles >18 mm was significantly higher in the letrozole + NAC group (P = 0.007). The ovulation and pregnancy rates were also significantly higher in the letrozole + NAC group (P = 0.045). No adverse side effects and no cases of ovarian hyperstimulation syndrome were observed in NAC group.
Conclusion: NAC is demonstrated to be a safe and well-tolerated adjuvant to letrozole and can increase the pregnancy rates in PCOS patients.
Keywords: Letrozole; N-acetylcysteine; ovulation; polycystic ovary syndrome; pregnancy rate.
Conflict of interest statement
There are no conflicts of interest.
N-Acetylcysteine as an adjuvant to clomiphene citrate for successful induction of ovulation in infertile patients with polycystic ovary syndrome.J Obstet Gynaecol Res. 2012 Sep;38(9):1182-6. doi: 10.1111/j.1447-0756.2012.01844.x. Epub 2012 Apr 30. J Obstet Gynaecol Res. 2012. PMID: 22540635 Clinical Trial.
Clomiphene citrate or letrozole for ovulation induction in women with polycystic ovarian syndrome: a prospective randomized trial.Fertil Steril. 2009 Sep;92(3):849-52. doi: 10.1016/j.fertnstert.2007.02.062. Epub 2007 Jun 19. Fertil Steril. 2009. PMID: 17582406 Clinical Trial.
Letrozole versus Clomiphene Citrate for Induction of Ovulation in Patients with Polycystic Ovarian Syndrome Undergoing Intrauterine Insemination.Clin Med Insights Reprod Health. 2011 Mar 14;5:11-6. doi: 10.4137/CMRH.S6598. eCollection 2011 Mar 14. Clin Med Insights Reprod Health. 2011. PMID: 24453507 Free PMC article.
Effects of Letrozole-HMG and Clomiphene-HMG on Incidence of Luteinized Unruptured Follicle Syndrome in Infertile Women Undergoing Induction Ovulation and Intrauterine Insemination: A Randomised Trial.Glob J Health Sci. 2015 Sep 1;8(4):244-52. doi: 10.5539/gjhs.v8n4p244. Glob J Health Sci. 2015. PMID: 26573024 Free PMC article. Clinical Trial.
The use of aromatase inhibitors for ovulation induction.Curr Opin Obstet Gynecol. 2015 Jun;27(3):206-9. doi: 10.1097/GCO.0000000000000163. Curr Opin Obstet Gynecol. 2015. PMID: 25710389 Review.
- Goodarzi MO, Dumesic DA, Chazenbalk G, Azziz R. Polycystic ovary syndrome: Etiology, pathogenesis and diagnosis. Nat Rev Endocrinol. 2011;7:219–31. - PubMed
- Kovacs G, Wood C. The current status of polycystic ovary syndrome. Aust N Z J Obstet Gynaecol. 2001;41:65–8. - PubMed
- Guzick D. Polycystic ovary syndrome: Symptomatology, pathophysiology, and epidemiology. Am J Obstet Gynecol. 1998;179:S89–93. - PubMed
- Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS) Hum Reprod. 2004;19:41–7. - PubMed
- Kitzinger C, Willmott J. 'The thief of womanhood': Women's experience of polycystic ovarian syndrome. Soc Sci Med. 2002;54:349–61. - PubMed